Daewoong's Nabota tops botulinum toxin exports
Daewoong Pharmaceutical said Tuesday that its botulinum toxin product, Nabota, posted 113.3 billion won ($85.3 million) in sales as of the third quarter this year.
Overseas sales made up 93.5 billion won or 83 percent of the total, the company added.
Nabota's overseas sales have continued growing in recent years, an outcome of Daewoon's global push. The portion reached 61 percent in 2021 and then surged to 77 percent last year.
US sales, in particular, reached 44.5 billion won, making up more than 50 percent of global sales.
“Nabota’s share in the US botulinum toxin market has surged over the last two years. We expect to further boost our share in the future," a Daewoong official said.
Nabota, sold as Jeuveau in the US, made its US debut in 2020 through local partner Evolus’ botulinum toxin treatment program. Nabota currently has around an 11 percent share in the US botulinum toxin market, according to the company.
“Nabota was able to take the lead among Korea’s botulinum toxin products as Daewoong set its plans ahead for its launch in the US and received approval from the US Food and Drug Administration fast,” said Park Seong-soo, vice president of Daewoong Pharmaceutical.
In South Korea, a total of 11 botulinum toxin products have received approval from the government so far, and three additional products are under review.
Daewoong said the company will speed up Nabota launches in European countries, including Germany, Italy and Austria.
The company added it would also make a foray into the Malaysian market soon. In August, Daewoong received sales approval from the National Pharmaceutical Regulatory Agency in Malaysia.
(责任编辑:부동산)
- ·FSS issues advisories to fisheries cooperatives federation for W50b investment loss
- ·야당 29명 반란, 이재명 방탄 뚫렸다
- ·[이번 주 리뷰]美 Fed 기준금리 동결…이재명 체포동의안 가결(18~23일)
- ·"KTX 꼭 타보고 싶다" 했던 김정은 "만족한 합의"…뭐길래
- ·한동훈, 체포안 설명 8분 넘기자…“짧게 합시다” “왜 이리 시끄럽냐”
- ·Incheon Airport passenger traffic to recover during Chuseok holiday
- ·합의문도 없는 희한한 북·러 정상회담…결국 비즈니스 관계였나
- ·Seoul shares start lower ahead of key rate decision
- ·China's consumer prices hit 3
- ·Ruling party to launch innovation committee after crushing by
- ·Kia reaches tentative agreement with union
- ·Import prices rise for 3rd month on higher oil costs
- ·4 contentious bills scrapped in revote after Yoon's veto
- ·Ruling party to launch innovation committee after crushing by
- ·[Herald Interview] Chile, Korea need to boost global lithium value chain: minister
- ·NY Met exhibition to mark 25th anniversary of Korean gallery
- ·SK carries out complete reshuffle of top brass
- ·[Herald Interview] Chile, Korea need to boost global lithium value chain: minister
- ·Fragile yet strong, G Gallery's 'Thick Skin' showcases two emerging artists
- ·S. Korea, US, Japan install trilateral communication hotline amid N. Korea, China challenges
- ·[KH Explains] Shipbuilders scramble to secure labor force amid booming industry
- ·FSC lays out plan to boost pet insurance enrollment
- ·Ateez lands on UK chart with 2nd LP, to go on world tour
- ·Foreign workers' deaths get weak sanctions
- ·S. Korea, US and Japan to conduct joint aerial exercise for 1st time: source
- ·Biden to visit Israel as war in Gaza sparks humanitarian crisis
- ·In revote, National Assembly strikes down controversial media bills
- ·SK Chemicals partners with Estee Lauder for eco